US Stock MarketDetailed Quotes

BIVI BioVie

Watchlist

2.640
+0.050+1.93%

Close Dec 13 16:00 ET

2.680
+0.040+1.52%

Post 19:58 ET

46.91MMarket Cap-0.52P/E (TTM)

BioVie Stock Forum

Jaguar8

Nov 20 07:07

NEWS

$BioVie (BIVI.US)$
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie (NASDAQ: BIVI) announced the acceptance of an abstract detailing their planned Phase 2 trial of bezisterim for Long COVID treatment at the Demystifying Long COVID International Conference in Barcelona. The study, fully funded by the U.S. Department of Defense, will be a double-blind, randomized, placebo-controlled tri...

InfiltradeR

Nov 13 08:52

$BioVie (BIVI.US)$ Earning report after bell today?

$BioVie (BIVI.US)$ 👀

Pre Market Ticks. 5:35am 11/7/24

$BioVie (BIVI.US)$ $Dutch Bros (BROS.US)$ $Freshworks (FRSH.US)$ $Laird Superfood (LSF.US)$ $Guardant Health (GH.US)$ $Bluejay Diagnostics (BJDX.US)$ $Emergent BioSolutions (EBS.US)$ $Ensysce Biosciences (ENSC.US)$ $Lyft Inc (LYFT.US)$ $Applovin (APP.US)$ $Interactive Strength (TRNR.US)$ $AtlasClear (ATCH.US)$ $MDJM Ltd (MDJH.US)$
📊⚡️📊

Trytosaveabit

Nov 4 07:00

Update

$BioVie (BIVI.US)$ Reuters· just
Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded

Jaguar8

Oct 28 20:59

Caution on this. 3 consecutive offerings within 3 weeks.

NEWS

$BioVie (BIVI.US)$
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BioVie Inc (NASDAQ: BIVI) announced the pricing of a registered direct offering of 1,146,000 shares of common stock at $2.83 per share, aiming to raise approximately $3.2 million in gross proceeds. The offering, priced at-the-market under Nasdaq rules, is expected to close around October 29, 2024. The company plans to use the net proceeds for working capital and general corpo...